| 1 | Hepatocellular Adenoma | 39% |
| 2 | Mammary Neoplasms, Experimental | 31% |
| 3 | Peritoneal Neoplasms | 29.3% |
| 4 | Leukemia, Experimental | 28.5% |
| 5 | Sarcoma, Experimental | 27.5% |
| 6 | Gastrointestinal Neoplasms | 26.7% |
| 7 | Pancreatic Neoplasm | 26.5% |
| 8 | Melanoma, Experimental | 25.4% |
| 9 | Esophageal Neoplasms | 21.9% |
| 10 | Bile Duct Neoplasms | 18.8% |
| 11 | gallbladder neoplasm | 18.8% |
| 12 | Intestinal Neoplasms | 18.8% |
| 13 | Stomach Neoplasms | 18.8% |
| 14 | Carcinoma, Pancreatic Ductal | 17.9% |
| 15 | Liver Cirrhosis, Experimental | 17.6% |
| 16 | Carcinoma 256, Walker | 17.5% |
| 17 | Carcinoma, Ehrlich Tumor | 17.2% |
| 18 | Carcinoma, Lewis Lung | 17.2% |
| 19 | Zollinger-Ellison syndrome | 16.6% |
| 20 | Biliary cirrhosis | 15.3% |
| 21 | Colorectal Neoplasms | 15.2% |
| 22 | Cecal Neoplasms | 14.7% |
| 23 | Duodenal Neoplasms | 14.7% |
| 24 | Adenomatous Polyposis Coli | 14.7% |
| 25 | Vipoma | 14.3% |
| 26 | insulinoma | 14.2% |
| 27 | Gastrinoma | 14.1% |
| 28 | Glucagonoma | 14.1% |
| 29 | Multiple Endocrine Neoplasia | 13.9% |
| 30 | Fatty Liver | 13.5% |
| 31 | Hepatitis | 13.5% |
| 32 | Portal Hypertension | 13.5% |
| 33 | Liver Cirrhosis | 13.5% |
| 34 | Focal Nodular Hyperplasia | 13.5% |
| 35 | Hepatic Insufficiency | 13.5% |
| 36 | Steatohepatitis | 13.5% |
| 37 | Leukemia L1210 | 13.3% |
| 38 | Leukemia P388 | 13.3% |
| 39 | Fatty Liver, Alcoholic | 13.3% |
| 40 | Hepatitis, Alcoholic | 13.3% |
| 41 | Liver Cirrhosis, Alcoholic | 13.3% |
| 42 | Abdominal Neoplasms | 12.9% |
| 43 | Head and Neck Neoplasms | 12.9% |
| 44 | Soft Tissue Neoplasms | 12.9% |
| 45 | Thoracic Neoplasms | 12.9% |
| 46 | Gastrointestinal Stromal Tumors | 12.9% |
| 47 | Sarcoma 180 | 12.8% |
| 48 | Choledochal Cyst | 12.4% |
| 49 | Appendiceal Neoplasms | 12.3% |
| 50 | Colonic Neoplasms | 12.3% |
| 51 | Rectal Neoplasms | 12.3% |
| 52 | Pancreatic Cyst | 12.1% |
| 53 | Hamartoma | 12.1% |
| 54 | Neoplasms, Hormone-Dependent | 12.1% |
| 55 | Neoplasms, Multiple Primary | 12.1% |
| 56 | Paraneoplastic Syndromes | 12.1% |
| 57 | Precancerous Conditions | 12.1% |
| 58 | Neoplasms, Second Primary | 12.1% |
| 59 | Liver Diseases, Parasitic | 11.9% |
| 60 | Paraneoplastic Encephalomyelitis | 11.9% |
| 61 | Hepatic Veno-Occlusive Disease | 11.7% |
| 62 | Peliosis Hepatis | 11.7% |
| 63 | Hepatopulmonary Syndrome | 11.7% |
| 64 | Anus Neoplasms | 11.6% |
| 65 | Sigmoid Neoplasms | 11.6% |
| 66 | Hepatomegaly | 11.5% |
| 67 | Biliary Tract Diseases | 11.5% |
| 68 | Gastrointestinal Diseases | 11.5% |
| 69 | Pancreatic Diseases | 11.5% |
| 70 | Hepatic Vein Thrombosis | 11.5% |
| 71 | Liver Abscess | 11.5% |
| 72 | Budd-Chiari Syndrome | 11.5% |
| 73 | Esophageal and Gastric Varices | 11.4% |
| 74 | Endocrine Gland Neoplasms | 11.4% |
| 75 | Eye Neoplasms | 11.4% |
| 76 | Nervous System Neoplasms | 11.4% |
| 77 | Parathyroid Neoplasms | 11.3% |
| 78 | Thyroid Neoplasm | 11.3% |
| 79 | Thyroid carcinoma | 11.3% |
| 80 | Bone neoplasms | 11.2% |
| 81 | Skin Neoplasms | 11.2% |
| 82 | Hematologic Neoplasms | 11.2% |
| 83 | Splenic Neoplasms | 11.1% |
| 84 | Liver Abscess, Amebic | 10.7% |
| 85 | Acanthoma | 10.4% |
| 86 | Cyst | 10.4% |
| 87 | Neoplastic Processes | 10.4% |
| 88 | Neoplastic Syndromes, Hereditary | 10.4% |
| 89 | Pregnancy Complications, Neoplastic | 10.4% |
| 90 | Chemical and Drug Induced Liver Injury | 10.3% |
| 91 | Carcinoma, Lobular | 10.2% |
| 92 | Pancreatic Fistula | 10.1% |
| 93 | Barrett Esophagus | 10.1% |
| 94 | Hepatorenal Syndrome | 10% |
| 95 | Medulloblastoma | 10% |
| 96 | Arthritis, Experimental | 10% |
| 97 | Meningioma | 9.9% |
| 98 | Tracheal Neoplasms | 9.7% |
| 99 | Multiple Endocrine Neoplasia Type 1 | 9.6% |
| 100 | Dermoid Cyst | 9.6% |
| 101 | Neoplasms, Neuroepithelial | 9.5% |
| 102 | Gliomatosis cerebri | 9.5% |
| 103 | Tuberous Sclerosis | 9.4% |
| 104 | Trophoblastic Neoplasms | 9.2% |
| 105 | Neoplasms, Radiation-Induced | 9% |
| 106 | Porphyrias, Hepatic | 9% |
| 107 | Digestive System Neoplasms | 8.9% |
| 108 | Hepatitis, Chronic | 8.9% |
| 109 | Liver Failure | 8.9% |
| 110 | Non-alcoholic Fatty Liver Disease | 8.9% |
| 111 | Chronic active hepatitis | 8.9% |
| 112 | Proctocolitis | 8.8% |
| 113 | Diabetes Mellitus, Experimental | 8.8% |
| 114 | melanoma | 8.6% |
| 115 | Neuroectodermal Tumors | 8.6% |
| 116 | Acoustic Neuroma | 8.6% |
| 117 | Mesenteric vascular insufficiency | 8.5% |
| 118 | Esophageal Atresia | 8.4% |
| 119 | Intestinal Atresia | 8.4% |
| 120 | Mesenteric Vascular Occlusion | 8.4% |
| 121 | Intestinal Fistula | 8.4% |
| 122 | Enterocutaneous Fistula | 8.4% |
| 123 | Retroperitoneal Neoplasms | 8.3% |
| 124 | Thymoma | 8.3% |
| 125 | Retinoblastoma | 8.3% |
| 126 | Leukemia, Radiation-Induced | 8.2% |
| 127 | Pancreatic Pseudocyst | 8.1% |
| 128 | Thyroid Nodule | 8.1% |
| 129 | Choriocarcinoma | 8% |
| 130 | Hepatitis B, Chronic | 8% |
| 131 | Hepatitis C, Chronic | 8% |
| 132 | Testicular Neoplasms | 7.9% |
| 133 | Nephroblastoma | 7.9% |
| 134 | Hepatitis, Animal | 7.8% |
| 135 | Hepatitis, Viral, Human | 7.8% |
| 136 | Adenoma, Acidophil | 7.8% |
| 137 | Ganglioneuroma | 7.8% |
| 138 | Glioma | 7.8% |
| 139 | Malignant Glioma | 7.8% |
| 140 | Liver neoplasms | 7.6% |
| 141 | Dysentery | 7.6% |
| 142 | Enteritis | 7.6% |
| 143 | Enterocolitis | 7.6% |
| 144 | Esophagitis | 7.6% |
| 145 | Gastritis | 7.6% |
| 146 | Inflammatory Bowel Diseases | 7.6% |
| 147 | Cholecystolithiasis | 7.6% |
| 148 | Carcinosarcoma | 7.6% |
| 149 | Hemangiosarcoma | 7.6% |
| 150 | lymphangiosarcoma | 7.6% |
| 151 | Duodenitis | 7.4% |
| 152 | Ileitis | 7.4% |
| 153 | Erosive Duodenitis | 7.4% |
| 154 | Leukoplakia, Oral | 7.4% |
| 155 | Carcinoid Tumor | 7.4% |
| 156 | Neurilemmoma | 7.4% |
| 157 | Hutchinson's Melanotic Freckle | 7.4% |
| 158 | Melanoma, Amelanotic | 7.4% |
| 159 | Paraneoplastic Cerebellar Degeneration | 7.4% |
| 160 | Optic Nerve Glioma | 7.3% |
| 161 | Rectal Fistula | 7.3% |
| 162 | Anal Fistula | 7.3% |
| 163 | Erythroplasia | 7.3% |
| 164 | Follicular cyst | 7.3% |
| 165 | leukemia | 7.3% |
| 166 | Mucocele | 7.3% |
| 167 | Neoplasms, Germ Cell and Embryonal | 7.3% |
| 168 | Neoplasms, Glandular and Epithelial | 7.3% |
| 169 | Pilonidal Cyst | 7.3% |
| 170 | Thyroglossal Cyst | 7.3% |
| 171 | Synovial Cyst | 7.3% |
| 172 | Germ Cell Cancer | 7.3% |
| 173 | Aberrant Crypt Foci | 7.3% |
| 174 | Basal Cell Nevus Syndrome | 7.3% |
| 175 | Mouth Neoplasms | 7.2% |
| 176 | Central Nervous System Neoplasms | 7.2% |
| 177 | Vascular Neoplasms | 7.2% |
| 178 | Thymus Neoplasms | 7.2% |
| 179 | Genital Neoplasms, Female | 7.1% |
| 180 | Breast Neoplasms, Male | 7.1% |
| 181 | Triple Negative Breast Neoplasms | 7.1% |
| 182 | Peutz-Jeghers Syndrome | 7% |
| 183 | Lymphomatoid Granulomatosis | 7% |
| 184 | Radiation Injuries, Experimental | 6.9% |
| 185 | Astrocytoma | 6.9% |
| 186 | Ependymoma | 6.9% |
| 187 | oligodendroglioma | 6.9% |
| 188 | Ganglioglioma | 6.9% |
| 189 | gliosarcoma | 6.9% |
| 190 | Anaplastic astrocytoma | 6.9% |
| 191 | Anaplastic Oligodendroglioma | 6.9% |
| 192 | Bile Duct Diseases | 6.7% |
| 193 | Cholelithiasis | 6.7% |
| 194 | Chylous Ascites | 6.7% |
| 195 | Esophageal Diseases | 6.7% |
| 196 | Gastroenteritis | 6.7% |
| 197 | Intestinal Diseases | 6.7% |
| 198 | Pancreatic Insufficiency | 6.7% |
| 199 | Pancreatitis | 6.7% |
| 200 | Pneumoperitoneum | 6.7% |
| 201 | Stomach Diseases | 6.7% |
| 202 | Malignant Carcinoid Syndrome | 6.7% |
| 203 | Fascioliasis | 6.7% |
| 204 | Echinococcosis, Hepatic | 6.7% |
| 205 | Chemical and Drug Induced Liver Injury, Chronic | 6.7% |
| 206 | Reye Syndrome | 6.6% |
| 207 | Colitis | 6.6% |
| 208 | Duodenogastric Reflux | 6.6% |
| 209 | Peptic Ulcer | 6.6% |
| 210 | Proctitis | 6.6% |
| 211 | Choledocholithiasis | 6.6% |
| 212 | Liver Failure, Acute | 6.6% |
| 213 | End Stage Liver Disease | 6.6% |
| 214 | Composite Lymphoma | 6.6% |
| 215 | Leukemia, Plasma Cell | 6.6% |
| 216 | Basal cell carcinoma | 6.6% |
| 217 | Carcinoma, Papillary | 6.6% |
| 218 | Squamous cell carcinoma | 6.6% |
| 219 | Chondrosarcoma | 6.6% |
| 220 | Craniopharyngioma | 6.6% |
| 221 | Cystadenoma | 6.6% |
| 222 | leiomyosarcoma | 6.6% |
| 223 | liposarcoma | 6.6% |
| 224 | Mesothelioma | 6.6% |
| 225 | synovial sarcoma | 6.6% |
| 226 | Neuroectodermal Tumor, Melanotic | 6.6% |
| 227 | Angiomyolipoma | 6.6% |
| 228 | Clear Cell Sarcoma of Soft Tissue | 6.6% |
| 229 | Alveolar Soft Part Sarcoma | 6.6% |
| 230 | Neuroendocrine Tumors | 6.6% |
| 231 | Sarcoma, Myeloid | 6.6% |
| 232 | Carcinoma, Basal Cell | 6.6% |
| 233 | Limbic Encephalitis | 6.6% |
| 234 | Glioblastoma | 6.5% |
| 235 | Neuroblastoma | 6.5% |
| 236 | Glioblastoma Multiforme | 6.5% |
| 237 | Adrenal Gland Neoplasms | 6.4% |
| 238 | Genital Neoplasms, Male | 6.4% |
| 239 | Uveal Neoplasms | 6.4% |
| 240 | Leukoplakia | 6.3% |
| 241 | Lymphocele | 6.3% |
| 242 | Ganglioneuroblastoma | 6.3% |
| 243 | Urologic Neoplasms | 6.3% |
| 244 | Breast Cyst | 6.2% |
| 245 | Histiocytic Disorders, Malignant | 6.2% |
| 246 | Actinic keratosis | 6.2% |
| 247 | Mediastinal Cyst | 6.2% |
| 248 | Neoplasm Invasiveness | 6.2% |
| 249 | Neoplasm Metastasis | 6.2% |
| 250 | Neoplasm Recurrence, Local | 6.2% |
| 251 | Parovarian Cyst | 6.2% |
| 252 | Pericardial Cyst | 6.2% |
| 253 | Sebaceous Gland Neoplasms | 6.2% |
| 254 | Spinal Neoplasms | 6.2% |
| 255 | Thymic Cyst | 6.2% |
| 256 | Bone Marrow Neoplasms | 6.2% |
| 257 | Carcinogenesis | 6.2% |
| 258 | Myxoid cyst | 6.2% |
| 259 | Metastasis | 6.2% |
| 260 | Leydig Cell Tumor | 6.2% |
| 261 | Nose Neoplasms | 6.2% |
| 262 | Pouchitis | 6.1% |
| 263 | Cystadenocarcinoma | 6.1% |
| 264 | Fibrosarcoma | 6.1% |
| 265 | Osteosarcoma | 6.1% |
| 266 | Mucoepidermoid Carcinoma | 6.1% |
| 267 | Lambert-Eaton Myasthenic Syndrome | 6.1% |
| 268 | Liver Neoplasms, Experimental | 6% |
| 269 | Palatal Neoplasms | 6% |
| 270 | Prolactinoma | 5.9% |
| 271 | Growth Hormone-Secreting Pituitary Adenoma | 5.9% |
| 272 | Adenofibroma | 5.9% |
| 273 | Fibroadenoma | 5.9% |
| 274 | Malignant Fibrous Histiocytoma | 5.9% |
| 275 | Variegate Porphyria | 5.9% |
| 276 | Acute intermittent porphyria | 5.9% |
| 277 | Porphyria Cutanea Tarda | 5.9% |
| 278 | Appendicitis | 5.8% |
| 279 | Anus, Imperforate | 5.8% |
| 280 | Gastrointestinal Hemorrhage | 5.8% |
| 281 | Hemoperitoneum | 5.8% |
| 282 | Mesenteric Panniculitis | 5.8% |
| 283 | Panniculitis, Peritoneal | 5.8% |
| 284 | Peritonitis | 5.8% |
| 285 | Peritoneal Fibrosis | 5.8% |
| 286 | Encapsulating Peritoneal Sclerosis | 5.8% |
| 287 | Anorectal Malformations | 5.8% |
| 288 | Carcinoid Heart Disease | 5.8% |
| 289 | Liver diseases | 5.7% |
| 290 | Biliary Fistula | 5.7% |
| 291 | Gastric Fistula | 5.7% |
| 292 | Autoimmune hepatitis | 5.7% |
| 293 | Tuberculosis, Gastrointestinal | 5.7% |
| 294 | Pituitary Adenoma | 5.7% |
| 295 | Pituitary Neoplasms | 5.7% |
| 296 | Neurofibrosarcoma | 5.7% |
| 297 | Crohn Disease | 5.7% |
| 298 | Duodenal Obstruction | 5.7% |
| 299 | Enterocolitis, Neutropenic | 5.7% |
| 300 | Necrotizing Enterocolitis | 5.7% |
| 301 | Bowen's Disease | 5.6% |
| 302 | Paraganglioma | 5.6% |
| 303 | Rhabdomyosarcoma | 5.6% |
| 304 | Giant Cell Tumor of Bone | 5.6% |
| 305 | Opsoclonus-Myoclonus Syndrome | 5.6% |
| 306 | Massive Hepatic Necrosis | 5.5% |
| 307 | Lymphoma | 5.5% |
| 308 | Endometrial Stromal Sarcoma | 5.4% |
| 309 | Corpus Luteum Cyst | 5.4% |
| 310 | Ovarian Cysts | 5.4% |
| 311 | Dermatofibrosarcoma | 5.4% |
| 312 | Dermatofibrosarcoma Protuberans | 5.4% |
| 313 | granulosa cell tumor | 5.4% |
| 314 | Carcinoma, Ovarian Epithelial | 5.4% |
| 315 | Mesoblastic Nephroma | 5.3% |
| 316 | Hydatidiform Mole | 5.3% |
| 317 | Zellweger Syndrome | 5.3% |
| 318 | Meningeal Neoplasms | 5.2% |
| 319 | Duodenal Ulcer | 5.2% |
| 320 | Peptic Ulcer Perforation | 5.2% |
| 321 | Gastric ulcer | 5.2% |
| 322 | Device Failure | 5.2% |
| 323 | Pheochromocytoma | 5.2% |
| 324 | Alveolar rhabdomyosarcoma | 5.2% |
| 325 | Hepatitis, Viral, Animal | 5.2% |
| 326 | Neuritis, Autoimmune, Experimental | 5.1% |
| 327 | Lymphangioleiomyomatosis | 5.1% |
| 328 | Myelitis, Transverse | 5.1% |
| 329 | Hepatitis E | 5.1% |
| 330 | Hepatitis B | 5% |
| 331 | Hepatitis C | 5% |
| 332 | Adenoma | 5% |
| 333 | Ameloblastoma | 5% |
| 334 | Angiokeratoma | 5% |
| 335 | Carcinoma | 5% |
| 336 | Chordoma | 5% |
| 337 | Hemangioma | 5% |
| 338 | hemangiopericytoma | 5% |
| 339 | Hepatitis A | 5% |
| 340 | Lymphangioma | 5% |
| 341 | Mesenchymoma | 5% |
| 342 | Nevus | 5% |
| 343 | Teratoma | 5% |
| 344 | Hepatoblastoma | 5% |
| 345 | Mixed Tumor, Mullerian | 5% |
| 346 | Germinoma | 5% |
| 347 | Teratocarcinoma | 5% |
| 348 | Angiofibroma | 5% |
| 349 | Sarcoma | 5% |
| 350 | Epithelioma | 5% |
| 351 | ovarian neoplasm | 5% |
| 352 | Hepatic Encephalopathy | 5% |
| 353 | Hepatolenticular Degeneration | 4.9% |
| 354 | Enterocolitis, Pseudomembranous | 4.9% |
| 355 | pseudomembranous colitis | 4.9% |
| 356 | Dysentery, Bacillary | 4.9% |
| 357 | Adrenocortical carcinoma | 4.9% |
| 358 | Cytogenetic Analysis | 4.9% |
| 359 | Electrophoresis | 4.9% |
| 360 | Ear Neoplasms | 4.6% |
| 361 | Eyelid Neoplasms | 4.6% |
| 362 | Lung Neoplasms | 4.6% |
| 363 | Pleural Neoplasms | 4.6% |
| 364 | Cystic Fibrosis | 4.6% |
| 365 | Colitis, Ischemic | 4.6% |
| 366 | Denys-Drash Syndrome | 4.6% |
| 367 | Brain Neoplasms | 4.6% |
| 368 | Salivary Gland Neoplasms | 4.6% |
| 369 | Spinal Cord Neoplasms | 4.6% |
| 370 | Tongue Neoplasms | 4.6% |
| 371 | Intubation | 4.5% |
| 372 | Uterine Neoplasms | 4.5% |
| 373 | Vaginal Neoplasms | 4.5% |
| 374 | Vulvar Neoplasms | 4.5% |
| 375 | Uterine Cancer | 4.5% |
| 376 | Fallopian Tube Neoplasms | 4.5% |
| 377 | Congenital Hyperinsulinism | 4.5% |
| 378 | Colonic Pseudo-Obstruction | 4.5% |
| 379 | Cecal Diseases | 4.4% |
| 380 | Cholangitis | 4.4% |
| 381 | Cholecystitis | 4.4% |
| 382 | Cholestasis | 4.4% |
| 383 | Colonic Diseases | 4.4% |
| 384 | Common Bile Duct Diseases | 4.4% |
| 385 | Esophageal Stenosis | 4.4% |
| 386 | Ileal Diseases | 4.4% |
| 387 | Intestinal Obstruction | 4.4% |
| 388 | Intestinal Perforation | 4.4% |
| 389 | Jejunal Diseases | 4.4% |
| 390 | Pneumatosis Cystoides Intestinalis | 4.4% |
| 391 | Rectal Diseases | 4.4% |
| 392 | Gastric Dilatation | 4.4% |
| 393 | Pancreatitis, Chronic | 4.4% |
| 394 | Gastric outlet obstruction | 4.4% |
| 395 | Cronkhite-Canada Syndrome | 4.4% |
| 396 | Intestinal Polyposis | 4.4% |
| 397 | Renal Cell Carcinoma | 4.4% |
| 398 | Papillary Renal Cell Carcinoma | 4.4% |
| 399 | Neoplasms, Experimental | 4.4% |
| 400 | Plasmacytoma | 4.3% |
| 401 | Malignant histiocytosis | 4.3% |
| 402 | Lymphatic Metastasis | 4.3% |
| 403 | Neoplasms, Unknown Primary | 4.3% |
| 404 | Leukemic Infiltration | 4.3% |
| 405 | Histiocytic sarcoma | 4.3% |
| 406 | Neoplasm Micrometastasis | 4.3% |
| 407 | Meningeal Carcinomatosis | 4.2% |
| 408 | Myasthenia Gravis, Autoimmune, Experimental | 4.2% |
| 409 | Pharyngeal Neoplasms | 4.2% |
| 410 | Carcinoma, Endometrioid | 4.1% |
| 411 | Central Nervous System Cysts | 4.1% |
| 412 | Nasopharyngeal carcinoma | 4.1% |
| 413 | Penile Neoplasms | 4.1% |
| 414 | Prostatic Neoplasms | 4.1% |
| 415 | Polycythemia Vera | 4% |
| 416 | Esophageal Perforation | 3.9% |
| 417 | Intestinal Diseases, Parasitic | 3.9% |
| 418 | Adenocarcinoma | 3.9% |
| 419 | Carcinoma in Situ | 3.9% |
| 420 | Carcinoma, Transitional Cell | 3.9% |
| 421 | Phyllodes Tumor | 3.9% |
| 422 | Dysgerminoma | 3.9% |
| 423 | Hemangioendothelioma | 3.9% |
| 424 | Lipoma | 3.9% |
| 425 | Myoma | 3.9% |
| 426 | Myxoma | 3.9% |
| 427 | Neuroma | 3.9% |
| 428 | Papilloma | 3.9% |
| 429 | Pseudomyxoma Peritonei | 3.9% |
| 430 | Seminoma | 3.9% |
| 431 | Papillomatosis | 3.9% |
| 432 | Angiolipoma | 3.9% |
| 433 | Myelolipoma | 3.9% |
| 434 | Neoplasms, Bone Tissue | 3.9% |
| 435 | Neoplasms, Fibrous Tissue | 3.9% |
| 436 | Smooth Muscle Tumor | 3.9% |
| 437 | Adenomatosis, Pulmonary | 3.9% |
| 438 | Adenomatous Polyps | 3.9% |
| 439 | Carcinoma, Large Cell | 3.9% |
| 440 | Carcinoma, Small Cell | 3.9% |
| 441 | Desmoplastic Small Round Cell Tumor | 3.9% |
| 442 | Chondroma | 3.9% |
| 443 | Enchondroma | 3.9% |
| 444 | Autopsy | 3.9% |
| 445 | Deglutition Disorders | 3.8% |
| 446 | Microscopy | 3.8% |
| 447 | Achlorhydria | 3.8% |
| 448 | Gastric Antral Vascular Ectasia | 3.8% |
| 449 | Peptic Ulcer Hemorrhage | 3.8% |
| 450 | Gastroparesis | 3.8% |
| 451 | Pancreatitis, Alcoholic | 3.8% |
| 452 | Bronchial Neoplasms | 3.8% |
| 453 | Laryngeal neoplasm | 3.8% |
| 454 | Multiple Pulmonary Nodules | 3.7% |
| 455 | Hodgkin Disease | 3.7% |
| 456 | Lymphoma, Non-Hodgkin | 3.7% |
| 457 | Polycystic Ovary Syndrome | 3.7% |
| 458 | Supratentorial Neoplasms | 3.7% |
| 459 | Endometrial Neoplasms | 3.7% |
| 460 | Bladder Neoplasm | 3.6% |
| 461 | Kidney Neoplasm | 3.6% |
| 462 | Ureteral Neoplasms | 3.6% |
| 463 | Urethral Neoplasms | 3.6% |
| 464 | Xeroderma Pigmentosum | 3.4% |
| 465 | Melena | 3.3% |
| 466 | Primary amyloidosis | 3.3% |
| 467 | Cholestasis, Extrahepatic | 3.3% |
| 468 | Biliary Dyskinesia | 3.3% |
| 469 | Cholangitis, Sclerosing | 3.3% |
| 470 | Colonic Diseases, Functional | 3.3% |
| 471 | Esophageal motility disorders | 3.3% |
| 472 | Fecal Incontinence | 3.3% |
| 473 | Fecal Impaction | 3.3% |
| 474 | Hypopharyngeal Neoplasms | 3.3% |
| 475 | Intussusception | 3.3% |
| 476 | Mallory-Weiss Syndrome | 3.3% |
| 477 | Megacolon | 3.3% |
| 478 | Pyloric Stenosis | 3.3% |
| 479 | Pleural Effusion, Malignant | 3.3% |
| 480 | Hypopharyngeal Cancer | 3.3% |
| 481 | Acalculous Cholecystitis | 3.3% |
| 482 | Ileus | 3.3% |
| 483 | Meconium ileus | 3.3% |
| 484 | Adenoid Cystic Carcinoma | 3.3% |
| 485 | fibroma | 3.3% |
| 486 | Fibromatosis | 3.3% |
| 487 | Hematemesis | 3.3% |
| 488 | Osteoblastoma | 3.3% |
| 489 | Osteoma | 3.3% |
| 490 | Rhabdomyoma | 3.3% |
| 491 | Chondromatosis | 3.3% |
| 492 | Adenocarcinoma, Clear Cell | 3.3% |
| 493 | Cholangiocarcinoma | 3.3% |
| 494 | Cervical Intraepithelial Neoplasia | 3.3% |
| 495 | Hemangioblastoma | 3.3% |
| 496 | Lymphoma, Extranodal NK-T-Cell | 3.3% |
| 497 | Leukemia, Myelomonocytic, Chronic | 3.3% |
| 498 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3.3% |
| 499 | Parotid Neoplasms | 3.3% |
| 500 | Prostatic Neoplasms, Castration-Resistant | 3.3% |
| 501 | Brain Stem Neoplasms | 3.3% |
| 502 | Nelson Syndrome | 3.3% |
| 503 | Choroid Plexus Papilloma | 3.1% |
| 504 | Rift Valley Fever | 3.1% |
| 505 | Fibromatosis, Aggressive | 3% |
| 506 | Fibromatosis, Abdominal | 3% |
| 507 | Klatskin Tumor | 3% |
| 508 | Nesidioblastosis | 2.9% |
| 509 | Mastocytosis | 2.9% |
| 510 | Sturge-Weber Syndrome | 2.9% |
| 511 | Tonsillar Neoplasms | 2.9% |
| 512 | Cell Transformation, Viral | 2.9% |
| 513 | Cerebellar Neoplasms | 2.9% |
| 514 | Hemangioma, Cavernous | 2.9% |
| 515 | Leukemia, T-Cell | 2.9% |
| 516 | Leukemia, B-Cell | 2.9% |
| 517 | neurofibroma | 2.9% |
| 518 | Hemorrhoids | 2.9% |
| 519 | Lymphoma, Follicular | 2.9% |
| 520 | T-Cell Lymphoma | 2.9% |
| 521 | Mantle cell lymphoma | 2.9% |
| 522 | Afferent Loop Syndrome | 2.8% |
| 523 | Celiac Disease | 2.8% |
| 524 | Short Bowel Syndrome | 2.8% |
| 525 | Sprue, Tropical | 2.8% |
| 526 | Steatorrhea | 2.8% |
| 527 | Rectocele | 2.8% |
| 528 | Sprue | 2.8% |
| 529 | Mastocytoma | 2.8% |
| 530 | Diverticulitis | 2.8% |
| 531 | Dumping Syndrome | 2.8% |
| 532 | Rectal Prolapse | 2.8% |
| 533 | Mastocytosis, Systemic | 2.8% |
| 534 | Leukemia, Myeloid, Chronic-Phase | 2.8% |
| 535 | Gastric Lavage | 2.8% |
| 536 | Peritoneal lavage | 2.8% |
| 537 | Bronchoalveolar Lavage | 2.8% |
| 538 | Esophageal Achalasia | 2.8% |
| 539 | Anal Fissure | 2.8% |
| 540 | Intestinal Pseudo-Obstruction | 2.8% |
| 541 | Irritable Bowel Syndrome | 2.8% |
| 542 | Superior Mesenteric Artery Syndrome | 2.8% |
| 543 | Emphysematous Cholecystitis | 2.8% |
| 544 | Neurogenic Bowel | 2.8% |
| 545 | Sphincter of Oddi Dysfunction | 2.8% |
| 546 | Anal Ulcer | 2.8% |
| 547 | Nasopharyngeal Neoplasms | 2.7% |
| 548 | Waldenstrom Macroglobulinemia | 2.7% |
| 549 | Multiple Myeloma | 2.7% |
| 550 | Giardiasis | 2.5% |
| 551 | Diverticulum | 2.5% |
| 552 | Diverticulosis | 2.5% |
| 553 | Paranasal Sinus Neoplasms | 2.5% |
| 554 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2.5% |
| 555 | Leukemia, Large Granular Lymphocytic | 2.5% |
| 556 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.5% |
| 557 | Lymphoma, T-Cell, Cutaneous | 2.4% |
| 558 | Lymphoma, AIDS-Related | 2.4% |
| 559 | Enteropathy-Associated T-Cell Lymphoma | 2.4% |
| 560 | Primary Effusion Lymphoma | 2.4% |
| 561 | Prosthesis Failure | 2.4% |
| 562 | Immunosuppression | 2.4% |
| 563 | Pruritus Ani | 2.4% |
| 564 | Dupuytren Contracture | 2.3% |
| 565 | Glasgow coma scale | 2.3% |
| 566 | Urticaria Pigmentosa | 2.3% |
| 567 | Mycosis Fungoides | 2.2% |
| 568 | Lymphomatoid Papulosis | 2.2% |
| 569 | Plasmablastic lymphoma | 2.2% |
| 570 | Biopsy | 2.2% |
| 571 | Lactose Intolerance | 2.2% |
| 572 | Maxillary Sinus Neoplasms | 2.2% |
| 573 | Laryngopharyngeal Reflux | 2.1% |
| 574 | Burkitt Lymphoma | 2% |
| 575 | Amniocentesis | 1.9% |
| 576 | Angioplasty | 1.9% |
| 577 | Cryptosporidiosis | 1.8% |
| 578 | Sezary Syndrome | 1.8% |
| 579 | Radicular Cyst | 1.8% |
| 580 | Polymerase Chain Reaction | 1.7% |
| 581 | Tuberculin Test | 1.6% |
| 582 | CREST Syndrome | 1.5% |
| 583 | Ovulation Induction | 1.4% |
| 584 | Blood culture | 1.4% |
| 585 | Immunoglobulin Therapy | 1.4% |
| 586 | Leukapheresis | 1.2% |
| 587 | Atherectomy | 1.1% |
| 588 | Body mass index | 1.1% |
| 589 | Paracentesis | 0.9% |
| 590 | PROTHROMBIN TIME | 0.8% |
| 591 | Glucose tolerance test | 0.8% |
| 592 | Superovulation | 0.8% |
| 593 | Clot retraction | 0.8% |
| 594 | venipuncture | 0.7% |
| 595 | Body Height | 0.7% |
| 596 | Body Weight | 0.7% |
| 597 | Birth Weight | 0.5% |
| 598 | Fetal Weight | 0.4% |
